Published December 3, 2009
| Version v1
Patent
Open
THERAPEUTICS TO INHIBIT MLL-MENIN INTERACTION FOR TREATING LEUKEMIA
Contributors
Patent applicant:
Description
Cell permeable peptides derived from MLL that block the interaction of MLL with menin for the treatment of acute mycloid and acute lymphoid leukemia are disclosed. Small molecules interfere with the interaction of MLL with any of its binding partners.
Files
US20090298772.pdf
Files
(799.7 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:788668eddea6452c04d4543c459e760e
|
799.7 kB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 44620607 A
- Patent number
- US 8242078 B2
- Other
- oai:uchicago.tind.io:7744
Dates
- Patent filed
-
2007-10-19